Minimum inhibitory and bacterial concentrations of theaflavin and synergistic combinations with epicatechin and quercetin against clinical isolates of Stenotrophomonas Maltophilia by Betts, Jonathan et al.
	 	
	
 
 
This is the published version:  
 
Betts,	Jonathan,	Murphy,	Christine,	Kelly,	Stephen	and	Haswell,	Stephen	2012,	Minimum	
inhibitory	and	bacterial	concentrations	of	theaflavin	and	synergistic	combinations	with	
epicatechin	and	quercetin	against	clinical	isolates	of	Stenotrophomonas	Maltophilia,	Journal	of	
microbiology,	biotechnology	and	food	sciences,	vol.	1,	no.	5,	pp.	1250‐1258.	
	
	
Available from Deakin Research Online: 
 
http://hdl.handle.net/10536/DRO/DU:30063532	
	
	
	
Reproduced	with	the	kind	permission	of	the	copyright	owner	
	
	
Copyright	:	2012,	Slovak	University	of	Agriculture	in	Nitra	
          Journal of Microbiology,  
         Biotechnology and                                                                   Betts et al. 2012 : 1 (5) 1250-1258 
         Food Sciences                                                                                               
 
 
1250 
 
  
 
REGULAR ARTICLE 
 
MINIMUM INHIBITORY AND BACTERICIDAL CONCENTRATIONS OF 
THEAFLAVIN AND SYNGERGISTIC COMBINATIONS WITH EPICATECHIN 
AND QUERCETIN AGAINST CLINICAL ISOLATES OF STENOTROPHOMONAS 
MALTOPHILIA 
 
Jonathan Betts*1, Christine Murphy2, Stephen Kelly1 and Stephen Haswell1  
 
1Department of Chemistry, Faculty of Science,  University of Hull, Cottingham Road, Hull, 
HU6 7RX, UK.  
2Department of Biological Sciences, Faculty of Science, University of Hull, Cottingham 
Road, Hull, HU6 7RX, UK 
 
 Address*: Dr Jonathan Betts, Department of Chemistry, Faculty of Science,  University of 
Hull, Cottingham Road, Hull, HU6 7RX, United Kingdom. email: Jono.betts@btinternet.com, 
phone number: +447716141359 
 
 
ABSTRACT 
 
Stenotrophomonas maltophilia is an important nosocomial pathogen with intrinsic 
resistance to multiple antibiotics. Previous investigations have shown flavanols from black tea 
to possess antibacterial activity. This study describes the determination of minimum 
inhibitory concentrations and minimum bactericidal concentration for theaflavin 
independently and in formulations with the polyphenols epicatechin and quercetin against 
nine clinical isolates of Stenotrophomonas maltophilia and the control isolate NCTC 130141 
via the microtitre assay. The results demonstrate that theaflavin has strong antibacterial 
activity and also shows significant synergism with epicatechin and quercetin.  The minimum 
inhibitory concentrations of the isolates range between 200-400 g/mL for theaflavin and 
100-200 g/mL for both theaflavin:epicatechin and theaflavin:quercetin combinations. The 
minimum bactericidal concentrations were discovered to be a 2 fold increase on those of the 
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minimum inhibitory concentrations. The research highlights the potential use of polyphenols 
for the clinical treatment of highly antibiotic resistant bacteria.  
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INTRODUCTION  
 
The gram negative bacterium Stenotrophomonas maltophilia is an emergent hospital 
pathogen of significant importance due to its intrinsic and acquired multi-antibiotic resistance 
(Alonso and Martinez, 1997). As a nosocomial pathogen the bacterium typically affects 
patients who are immunocompromised (Looney et al., 2009) or those subjected to invasive 
procedures and prosthetic devices that circumvent normal protections. Numerous resistance 
genes have been identified in S. maltophilia enabling the bacterium to disable the activity of 
several important antibiotics via mechanisms including a multidrug efflux system (Zhang et 
al., 2000) and -lactamases (Gould et al., 2006). Surveillance studies (Betriu et al., 2001) 
have indicated the importance of good infection control to avert the cross-transmission of S. 
maltophilia within hospitals. 
To combat the growing problem of resistance to antibiotics, much research is being 
undertaken into the antibacterial properties of other natural compounds. One group that show 
antibacterial effects against a variety of bacterial species are polyphenols and investigations 
have already established that polyphenols such as epigallocatechin gallate (EGCG) and 
theaflavins are active against pathogens including S. maltophilia (Gordon and Wareham, 
2010), Shigella spp. (Vijaya et al., 1995) and Bacillus cereus (Friedman et al., 2006).  
Not only have polyphenols been shown to be effective independent antibacterial 
agents, but research has revealed their synergy with other antimicrobials. In a study with 
methicillin-resistant Staphylococcus aureus (MRSA), synergy was observed between EGCG 
and ampicillin/sulbactam (Hu et al., 2001). Other studies have demonstrated that polyphenols 
act synergistically with other antioxidants such as ascorbic acid (Hatano et al., 2008) where a 
protective effect of EGCG is exhibited by the protection of natural structural change. 
The antibacterial action of theaflavin against S. maltophilia and Acinetobacter 
baumannii, and the synergy between theaflavin and epicatechin, has been previously reported 
(Betts et al., 2011). However, the minimum inhibitory concentrations (MICs) and minimum 
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bactericidal concentrations (MBCs) have not been established against S. maltophilia. Any 
synergy of theaflavin with other common polyphenols has also yet to be identified.  
The objective of our study was to determine the MIC and MBC of theaflavin and a 
theaflavin:epicatechin combination against hospital isolates of S. maltophilia and to establish 
whether any significant synergy occurs between theaflavin and another common polyphenol, 
quercetin. 
 
MATERIAL AND METHODS 
 
Clinical isolates 
 
Nine strains of S. maltophilia were isolated on blood and MacConkey agar from 
sputum samples of respiratory patients at Hull Royal Infirmary, Hull, UK. They were 
identified using gram staining, antibiotic susceptibility evaluation and biochemical profiling 
using API 20E testing kits (BioMérieux, France.) A control strain of S. maltophilia (NCTC 
13014) was purchased from the Health Protection Agency Culture Collections, Porton Down, 
UK. 
 
Tea polyphenols, antibiotic discs and media 
 
Epicatechin (EC) with purity  90% and quercetin (Q) with purity  98% were 
purchased from Sigma-Aldrich, UK. Theaflavin (TF) with purity  95% was donated by 
Unilever, Shanghai, China. Iso-Sensitest broth, agar powders and antibiotic discs were 
purchased from Oxoid, UK.  
 
Antibiotic susceptibility testing 
 
Individual plates of Iso-Sensitest agar was innoculated with each isolate of                 
S. maltophilia using the standardized method by Moosden et al., (1988). To each plate 
one disc of ampicillin (AMP) 25 g, gentamycin (CN) 10 g, imipenem (IPM) 10 g, 
cefoxitin (FOX) 10 g, tetracycline (TE) 10 g and ciprofloxacin (CIP) 1 g was added. 
Zones of inhibition were measured after 24 hours incubation at 30C and antibiotic 
susceptibility of each isolate was determined. 
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Determination of minimum inhibitory and bactericidal concentrations  
 
A microtitre assay based on that of Andrews (2001) was performed to determine the 
MICs of EC, theaflavin (TF) and a (theaflavin:epicatechin) TF:EC and theaflavin:quercetin 
(TF:Q) combination against the nine clinical isolates and one control strain (NCTC 13014) of 
S. maltophilia. All antibiotics were diluted in DMSO to prepare stocks solutions of 80 mg/ml 
of TF and Q, 100 mg/ml of EC, and 80 mg:40 mg/ml for the TF:EC and TF:Q combinations.  
A serial dilution of each stock solution was then performed into sterile ISO-sensitive 
broth. A 40 L volume of stock solution was added to a sterile tube containing 2 mL of ISO-
sensitive broth. From this solution a double dilution was performed 4 times, providing 5 
different concentrations of the polyphenol in ISO-sensitive broth and a tube containing ISO-
sensitive broth only to use as a control.  
 
Table 1 Final polyphenol concentrations in the 96 well plate.  
TF Q EC TF:EC combi (2:1) TF:Q combi (2:1) 
800 g/mL 800 g/mL 1000 g/mL 800:400 g/mL 800:400 g/mL 
400 g/mL 400 g/mL 500 g/mL 400:200 g/mL 400:200 g/mL 
200 g/mL 200 g/mL 250 g/mL 200:100 g/mL 200:100 g/mL 
100 g/mL 100 g/mL 125 g/mL 100:50 g/mL 100:50 g/mL 
50 g/mL 50 g/mL 62.5 g/mL 50:25 g/mL 50:25 g/mL 
0 g/mL  0 g/mL  0 g/mL  0 g/mL  0 g/mL  
TF - theaflavin, Q - quercetin, EC - epicatechin, TF:EC - theaflavin:epicatechin combination and TF:Q - 
theaflavin:quercetin combination 
 
For each concentration of TF in broth, 75 L was pipetted into 10 horizontal wells of a 
96 well cell culture plate (1 well per concentration per bacterial isolate). An isolate of 
S. maltophilia was pipetted into each well as a 75 L volume of 0.5 MacFarland suspension. 
The procedure was repeated for each compound and the combinations, giving final well 
concentrations as shown in Table 1. Each plate was incubated in a rocking incubator at 30C 
for 24 h. Following incubation wells were observed for turbidity. MICs were taken as the 
lowest concentrations not showing any visible growth.  
Minimum bactericidal concentration was also determined by removing 2 L volume 
of the medium from each microtitre plate well (containing polyphenol) and spotting onto ISO-
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sensitive agar. Agar plates were incubated for a further for 18 h at 30C. Any growth 
observed from the spots was designated as an ineffective bactericidal concentration of 
compound. For each test 6 replicates were undertaken.  
 
RESULTS AND DISCUSSION 
 
The results from the susceptibility testing shows various degrees in antibiotic 
resistance (Table 2). All isolates showed resistance to ampicilin and imipenem and with the 
exception of the control, all isolates prestented resistance to cefoxin. High numbers of isolates 
were also resistant to tetracycline and mixed results were observed with gentamycin and 
ciprofloxacin. Isolate 7 presented the highest level of resistance, only being susceptible to 
ciprofloxacin. 
 
Table 2. Antibiotic susceptibility profiles for S. maltophilia isolates 
Isolate AMP CN IPM TE FOX CIP 
1 R S R R R R 
2 R S R R R R 
3 R S R R R R 
4 R S R S R S 
5 R S R R R R 
6 R S R S R S 
7 R R R R R S 
8 R S R R R S 
9 R S R R R S 
Control  R S R R S R 
AMP - ampicillin (25 g), CN - gentamycin (10 g), IPM - imipenem (10 g), TE - tetracycline (10 g), FOX - 
cefoxitin (10 g) and CIP - ciprofloxacin (1 g). R - resistant, S - Susceptible. Control -  NCTC 13014 
 
The results from the MIC determination confirm that EC has no antibacterial effect 
against the strains of S. maltophilia used in this study. Concentrations of up to 1 mg/mL of 
EC did not inhibit the growth of S. maltophilia and therefore no MIC was achieved. Quercetin 
also showed no antibacterial effect against any strain of S. maltophilia. Concentrations of up 
to 800 g/mL of Q did not inhibit S. maltophilia growth. 
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The MIC results for TF confirmed that the polyphenol exhibited antibacterial effects 
when used in a liquid culture. The MIC of TF ranged between 200 g/mL and 400 g/mL as 
shown in Table 3. For the TF:EC and the TF:Q combinations the MIC value ranged between 
100 g/mL and 200 g/mL (Table 3). These were significantly lower than when using TF 
alone. The S. maltophilia control strain (NCTC 13014) had MICs of 200 g/mL with TF, 100 
g/mL for the TF:EC combination and 100 g/mL for the TF:Q combination.  
 
Table 3 Minimum inhibitory concentrations of polyphenols against clinical isolates and  
a control of Stenotrophomonas maltophilia (g /mL). 
Isolate no. TF Q EC 
TF:EC 
combi (2:1) 
TF:Q combi 
(2:1) 
1 200 N/A N/A 100:50 100:50 
2 200 N/A N/A 100:50 100:50 
3 400 N/A N/A 200:100 200:100 
4 200 N/A N/A 100:50 100:50 
5 400 N/A N/A 200:100 200:100 
6 200 N/A N/A 100:50 100:50 
7 400 N/A N/A 200:100 200:100 
8 200 N/A N/A 100:50 100:50 
9 200 N/A N/A 100:50 100:50 
Control 200 N/A N/A 100:50 100:50 
N/A - Not applicable, MIC not reached. Control - NCTC 13014 
Results from minimum bactericidal concentrations showed that twice the 
concentration of compound was required for bactericidal activity compared with that for MIC. 
However, a reduction in antibacterial activity was seen after stock solutions (in DMSO) were 
stored for 7 days at 4C. The concentrations of TF, TF:EC and TF:Q needed to be increased 2 
fold from previous testing to achieve their MICs. After 14 days MICs remained the same as 
those after 1 week in storage. 
It is clear from the results that TF and the combinations of TF:EC and TF:Q provide a 
significant antibacterial effect against the clinical isolates of S. maltophilia used here and the 
NCTC 13014 control strain. The result confirms previous research that reported a significant 
synergistic relationship exists between TF and EC (Betts et al., 2011) and indicates there is a 
similar effect when EC is substituted for Q. From the results it is apparent that supplementing 
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TF with EC (itself having no independent antibacterial effect) reduces the MIC of TF by half. 
This effect is reproduced when Q is added to TF. We believe this to be the first report in 
which the synergy between TF and Q is described and the first occasion that MICs for TF and 
combinations of TF with EC and TF with Q are presented.  
Possible mechanisms behind the antibacterial activity have yet to be fully determined. 
However, previous studies have linked the antimicrobial action of flavanols to inhibition of 
nucleic acid synthesis (Mori et al., 1987) and membrane damage from perforation (Ikaigai et 
al., 1993). A possible mechanism for the synergistic results observed in this study, is that a 
protective effect is afforded by EC and Q, as described by (Hatano et al., 2008), where the 
supplementary compounds reduce the structural change of TF due to natural oxidation. It is 
possible that EC and Q are more readily oxidised than TF in this situation, allowing the latter 
to retain its antibacterial activity.  
The increase in MIC after 7 days of storage at 4C is probably due to polyphenol 
oxidation. However, after an additional 7 days in storage the MIC did not change, indicating 
no further oxidation occurred. To minimise this it is recommended that all stock solutions 
should be stored under a nitrogen atmosphere in a freezer. Future research could investigate 
longer periods of storage to determine if any further reduction in antibacterial action occurs. 
In a clinical setting, by using a combination rather than singular antibacterial treatment 
potential resistance might be avoided. Another benefit is that the cost of treatment could be 
reduced by minimizing the amount of the more expensive TF used in polyphenol 
formulations. The findings indicate that there might be important clinical potential for these 
polyphenols as antibacterial agents, especially when used in combinations. Work is in 
progress to establish the mechanisms underlying the demonstrated antibacterial activity and 
synergy, and whether the bioavailability of the polyphenols could be sufficient for use in 
potential therapies for Stenotrophomonas infections at concentrations with tolerable side-
effects. 
 
CONCLUSION 
 
The results in this study show that theaflavin alone or in combination with epicatechin 
or quercetin shows great antibacterial activity against highly resistant isolates of                      
S. maltophilia. This highlights the potential application of natural products in the 
pharmaceutical and medical industry. With the great abundance and variety of natural 
compounds such as polyphenols, possibilities of synergistic treatments with other 
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polyphenols, procyanidins and with clinical antibiotics could increase our current arsenal in 
the fight against resistance. The significant importance of natural compounds for medicinal 
uses should not be underestimated. Their research and development could open up a new age 
of chemotherapeutic treatments. 
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